Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma (Q85224968)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 19, 2010

Language	Label	Description	Also known as
English	Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma	scientific article published on October 19, 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma (English)

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jianhua Yin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jiaxin Xie

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Shijian Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hongwei Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lei Han

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Wenying Lu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Qiuxia Shen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Guozhang Xu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hongjun Dong

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jie Shen

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jun Zhang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jiankang Han

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Lin Wang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yan Liu

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Fan Wang

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jun Zhao

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Qian Zhang

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Wu Ni

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Hongyang Wang

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Guangwen Cao

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20959817

6 August 2024

publication date

19 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

full work available at URL

http://www.nature.com/articles/ajg2010399.pdf

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

http://www.nature.com/articles/ajg2010399

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

https://journals.lww.com/00000434-201101000-00015

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

106

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

81-92

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

1 reference

20 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/MOLBEV/MSM092

Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention

1

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

2

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B virus genetic variability and evolution.

3

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B e antigen and the risk of hepatocellular carcinoma

4

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

5

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men.

6

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B virus taxonomy and hepatitis B virus genotypes

7

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Possible new hepatitis B virus genotype, southeast Asia

8

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J

9

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Clinical relevance and public health significance of hepatitis B virus genomic variations

10

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma

11

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

12

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

13

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

14

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B.

15

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma

16

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area

17

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D

18

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

20

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study.

21

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

22

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

23

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus.

24

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China

25

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

26

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

A1762T/G1764A mutations of hepatitis B virus, associated with the increased risk of hepatocellular carcinoma, reduce basal core promoter activities.

27

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.

28

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Prospective evaluation of hepatitis B 1762(T)/1764(A) mutations on hepatocellular carcinoma development in Shanghai, China

29

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

HBV A1762T, G1764A mutations are a valuable biomarker for identifying a subset of male HBsAg carriers at extremely high risk of hepatocellular carcinoma: a prospective study

30

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: story beyond A1762T/G1764A mutations

31

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis

32

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

X gene mutations in hepatitis B patients with cirrhosis, with and without hepatocellular carcinoma.

33

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F.

34

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Chronic hepatitis B.

35

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China

36

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.

38

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan

39

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management

40

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus

41

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Histological disease in Asian-Americans with chronic hepatitis B, high hepatitis B virus DNA, and normal alanine aminotransferase levels

42

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

43

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography

44

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Association between genomic heterogeneity of hepatitis B virus and intrauterine infection

45

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission

46

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients

47

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

The human mucin MUC4 is transcriptionally regulated by caudal-related homeobox, hepatocyte nuclear factors, forkhead box A, and GATA endodermal transcription factors in epithelial cancer cells.

48

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap.

49

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.

50

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma

51

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer

52

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.

53

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection

54

1 reference

10.1038/AJG.2010.399

https://api.crossref.org/works/10.1038/AJG.2010.399

6 August 2024

Identifiers

10.1038/AJG.2010.399

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20959817%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85224968&oldid=2222752608"